Israel Englander Esperion Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 300,000 shares of ESPR stock, worth $504,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300,000
Previous 5,681,744
94.72%
Holding current value
$504,000
Previous $15.2 Million
95.63%
% of portfolio
0.0%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding ESPR
# of Institutions
199Shares Held
136MCall Options Held
2.72MPut Options Held
1.3M-
Wasatch Advisors Inc Salt Lake City, UT16.9MShares$28.3 Million0.2% of portfolio
-
Black Rock Inc. New York, NY14MShares$23.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$18.2 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$16.7 Million0.37% of portfolio
-
Great Point Partners LLC Greenwich, CT5.79MShares$9.73 Million3.41% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $112M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...